Device Identification Records — The Implant Card and Operative Report
The single most important piece of evidence linking your specific device to the Bard PowerPort product line is the device identification information: the brand name (PowerPort), catalog number, lot number, and serial number. Patients typically receive an implant card from the implanting physician that contains this information. If you do not have your implant card, the operative report from your port placement procedure should contain the device identification data — hospitals are required to document implanted device information in surgical records under Joint Commission standards and the FDA's Universal Device Identifier (UDI) regulations. Your attorney can obtain this information through a medical records request to the implanting facility.
Imaging Reports — The Core Fracture Documentation
Imaging records are the primary documentation of the catheter fracture and fragment location. Relevant imaging includes: chest X-rays showing the radiodense catheter in an abnormal configuration or a separate fragment at a distal location; CT of the chest with 3D reconstruction showing the fragment's exact position within the vascular anatomy; fluoroscopy images from the retrieval procedure showing the fragment before and during retrieval; and echocardiography (heart ultrasound) reports documenting fragment location in the right heart or valve vegetations if infection occurred. Radiology reports — the written interpretations by radiologists — are as important as the images themselves and should be obtained along with the actual image files (CD or digital download from the radiology department).
Operative Reports and Pathology
The operative report from the catheter retrieval procedure — whether percutaneous or open surgical — documents the fragment's location at time of retrieval, its macroscopic appearance, and the specific retrieval technique used. If the fragment was sent to the hospital pathology laboratory (which is standard practice for retrieved foreign body material), the pathology report may identify the material as polyurethane and may describe degradation features such as cracking, brittleness, or surface oxidation. Pathology specimens may be preserved in the hospital's tissue storage indefinitely — your attorney can issue a preservation request to prevent routine destruction. All hospitalization records from fracture-related admissions, ICU stays, and surgical recoveries document the medical impact of the injury and support the damages calculation.
Financial Documentation and Lost Wages
Economic damages in a PowerPort lawsuit are supported by Explanation of Benefits (EOB) statements from your health insurer, hospital billing records, physician billing records, and pharmacy records — all documenting the medical costs attributable to the catheter fracture and its complications. Lost wages are documented by employment records, pay stubs, W-2s or tax returns showing income before and after the injury, and if applicable, documentation from your employer of medical leave taken due to PowerPort complications. If the injuries caused permanent disability affecting future earning capacity, vocational expert analysis and life care planning by a certified life care planner are used to project future economic losses. Your attorney will guide you through assembling all categories of economic documentation.
Related Pages
PowerPort Catheter Fracture — How It Happens
Bard PowerPort catheters fracture through a well-documented mechanism called environmental stress cracking (ESC) of polyurethane — a process that was scientifically foreseeable at the time of device design. The fracture is silent and painless, meaning most patients have no idea their catheter has broken until complications force diagnostic imaging.
PowerPort MDL Settlement Timeline — What to Expect
MDL mass tort litigation follows a predictable multi-year progression from case filing through bellwether trials to global settlement. Understanding each phase helps PowerPort plaintiffs set realistic expectations for timing and the factors that determine individual settlement amounts.
PowerPort Catheter Migration — Where Fragments Go
When a PowerPort catheter fractures, the free fragment enters the central venous circulation and travels to the heart and lungs following the path of venous blood flow. The fragment's final resting location determines the severity of injury — from retrievable right-heart positions to life-threatening peripheral pulmonary artery lodgment.
Bard PowerPort MDL in the District of Arizona
MDL No. 3:22-md-03062 in the U.S. District Court for the District of Arizona is the central federal forum for all Bard PowerPort catheter fracture cases. Understanding how the MDL works, where it currently stands, and what participation means for individual plaintiffs is essential for anyone considering a PowerPort lawsuit.
PowerPort vs. Other Port Catheters — Key Differences
The Bard PowerPort's polyurethane catheter is the defining design characteristic that distinguishes it from safer alternatives like Hickman catheters, silicone Mediport devices, and PICC lines — none of which use polyurethane tubing and none of which carry the same environmental stress cracking fracture risk.
PowerPort Removal Surgery — How Fractured Catheters Are Retrieved
Retrieval of a fractured PowerPort catheter fragment requires either percutaneous cardiac catheterization or open thoracic surgery, depending on fragment location and accessibility. The retrieval procedure itself carries procedural risks, and failure to retrieve leaves the patient with an ongoing foreign body infection and cardiac risk.
PowerPort Sepsis and Infection Risk
A fractured PowerPort catheter fragment acts as a permanent intravascular nidus for infection — a foreign body that bacteria colonize with a protective biofilm that antibiotics cannot eradicate without removing the fragment. For immunocompromised cancer patients, this infection risk is particularly life-threatening.
PowerPort Cardiac Perforation — Heart Surgery Risk
Cardiac perforation by a fractured PowerPort catheter fragment is a life-threatening emergency. The thin-walled right ventricle is particularly vulnerable to penetration by a fragment's sharp edge, causing cardiac tamponade — a surgical emergency that can be fatal within minutes without treatment.
Becton Dickinson Liability — BD's Acquisition of Bard
Becton, Dickinson and Company (BD) acquired C.R. Bard in 2017 for $24 billion and assumed full corporate liability for all Bard product claims, including the PowerPort. BD now faces claims not only for Bard's pre-acquisition conduct but also for BD's own post-acquisition decisions to continue selling the PowerPort without redesigning or adequately warning about the fracture risk.
Bard PowerPort Catheter Lawsuit
The Bard PowerPort is an implantable venous access device — a small port placed under the skin, typically in the chest — that allows medical professionals to administer chemotherapy, draw blood, and deliver medications without repeated needle sticks. Millions of patients have received PowerPort devices since C.R. Bard introduced them in the 1990s. The devices are especially common among cancer patients who require long-term intravenous access. Beginning in the early 2010s, patients, physicians, and researchers began documenting a disturbing pattern: the polyurethane catheter tubing attached to the port was fracturing inside the body. Fragments of the catheter — sometimes several centimeters long — were entering the bloodstream and migrating toward the heart and lungs. The resulting complications range from serious to fatal: cardiac perforation, cardiac tamponade, pulmonary embolism, sepsis, and endocarditis. Becton Dickinson (BD) acquired C.R. Bard in 2017 for $24 billion, inheriting both the PowerPort product line and the mounting litigation. In 2022, a federal multidistrict litigation was established in the U.S. District Court for the District of Arizona to consolidate cases nationwide. Legal claims proceed under theories of design defect, manufacturing defect, failure to warn, and negligence. Patients who received a PowerPort catheter and subsequently experienced catheter fracture, fragment migration, infection, cardiac complications, or unexplained symptoms may be entitled to substantial compensation.
View full case overview